CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.
Bueno C. et al, (2022), Blood, 140, 38 - 44
A tale of two alleles: TP53 and transformation in MPNs.
Brierley C. and Psaila B., (2022), Blood, 139, 3567 - 3568
In utero origin of myelofibrosis presenting in adult monozygotic twins.
Sousos N. et al, (2022), Nat Med, 28, 1207 - 1211
HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.
Li L. et al, (2022), Blood, 139, 2797 - 2815
The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy.
Strickland M. et al, (2022), Br J Haematol, 196, 1149 - 1158
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro.
Liu Z-J. et al, (2022), Blood Adv, 6, 13 - 27
Single-Cell Multi-Omics Reveals the Genetic, Cellular and Molecular Landscape of TP53 Mutated Leukemic Transformation in MPN
Rodriguez-Meira A. et al, (2021), BLOOD, 138
Message in a platelet: decoding platelet transcriptomes in myeloproliferative neoplasms.
Shapiro S. et al, (2021), Cell Rep Med, 2
Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development.
Roy A. et al, (2021), Cell Rep, 36
Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia.
Iskander D. et al, (2021), Sci Transl Med, 13
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.
Chowdhury O. et al, (2021), Br J Haematol, 194, 1010 - 1015
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
Salisbury RA. et al, (2021), Leukemia, 35, 2424 - 2430
Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021.
Mughal TI. et al, (2021), Haematologica, 106, 1787 - 1793
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Ahern DJ. et al, (2021)
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology.
Royston D. et al, (2021), Hematol Oncol Clin North Am, 35, 279 - 293
Application of Single Cell Approaches to Study MPN biology
MEAD A., (2021), Hematology / Oncology Clinics of North America
Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies.
Mughal TI. et al, (2020), Hematol Oncol, 38, 654 - 664